NCT00398788View on ClinicalTrials.gov

A Study on Efficacy (Effectiveness), Safety, and Impact on Quality of Life Measures of Dilaudid CR (Controlled Release);, Hydromorphone HCl in Patients With Chronic Low Back Pain

PHASE2CompletedINTERVENTIONAL
Enrollment

207

Participants

Timeline

Start Date

Not specified

Study Completion Date

November 30, 2001

Conditions
Low Back Pain
Interventions
DRUG

OROS® hydromorphone HCL; Dilaudid CR (controlled release); Dilaudid IR (immediate release) as rescue medicine

All Listed Sponsors
lead

Alza Corporation, DE, USA

INDUSTRY

NCT00398788 - A Study on Efficacy (Effectiveness), Safety, and Impact on Quality of Life Measures of Dilaudid CR (Controlled Release);, Hydromorphone HCl in Patients With Chronic Low Back Pain | Biotech Hunter | Biotech Hunter